[1]
E. Leon-rodriguez and M. M. Rivera-franco, “ORAL CYCLOSPORINE AS AN ALTERNATIVE FOR INITIAL STANDARD PROPHYLAXIS IN ALLOGENEIC STEM CELL TRANSPLANTATION WHEN INTRAVENOUS FORMULATION IS UNAVAILABLE”, Asian J Pharm Clin Res, vol. 11, no. 12, pp. 108–111, Dec. 2018.